热门资讯> 正文
Abivax推出4亿美元ADS产品
2025-07-24 14:26
- Abivax (NASDAQ:ABVX) has launched a public offering of American Depositary Shares (ADSs) in the U.S. to raise approximately $400 million (€340 million).
- Each ADS represents one ordinary share of the company. As part of the offering, Abivax intends to grant underwriters a 30-day option to purchase up to 15% additional ADSs on the same terms.
More on Abivax
- Abivax: Differentiated Phase 3 Data Ignites A Multi-Billion Dollar Opportunity
- Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout
- Abivax skyrockets 400% as late-stage trial for lead asset succeeds in ulcerative colitis
- Abivax reports Q1 results
- Seeking Alpha’s Quant Rating on Abivax
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
